Review



ctcs quantified by  (CellSearch inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CellSearch inc ctcs quantified by
    HSP70 exosomes compared to <t>CTCs</t> to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) <t>or</t> <t>circulating</t> tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.
    Ctcs Quantified By, supplied by CellSearch inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctcs quantified by/product/CellSearch inc
    Average 90 stars, based on 1 article reviews
    ctcs quantified by - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study"

    Article Title: Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study

    Journal: Journal of Extracellular Vesicles

    doi: 10.1080/20013078.2020.1766192

    HSP70 exosomes compared to CTCs to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) or circulating tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.
    Figure Legend Snippet: HSP70 exosomes compared to CTCs to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) or circulating tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.

    Techniques Used:



    Similar Products

    ctcs quantified by  (CellSearch inc)
    90
    CellSearch inc ctcs quantified by
    HSP70 exosomes compared to <t>CTCs</t> to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) <t>or</t> <t>circulating</t> tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.
    Ctcs Quantified By, supplied by CellSearch inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctcs quantified by/product/CellSearch inc
    Average 90 stars, based on 1 article reviews
    ctcs quantified by - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    HSP70 exosomes compared to CTCs to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) or circulating tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.

    Journal: Journal of Extracellular Vesicles

    Article Title: Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study

    doi: 10.1080/20013078.2020.1766192

    Figure Lengend Snippet: HSP70 exosomes compared to CTCs to discriminate metastatic from non-metastatic patients. ROC curve analysis for the detection level of HSP70 exosomes (left panel) or circulating tumour cells (CTCs, right panel), AUC = 0.8968, CI95% = [0.7387–1], p < 0.0001 compared to 0.7857, CI95% = [0.5873–0.9842], p = 0.0048.

    Article Snippet: Next, we compared circulating HSP70 exosomes with CTCs quantified by Cell-Search (a current FDA-approved approach), as predictors of tumour progression.

    Techniques: